2024 annual financial data
Trevi Therapeutics 2024 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -51,524,000 USD and net income was -47,911,000 USD.
Operating cash flow was -38,256,000 USD.
Get free Trevi Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -51,524,000 USD
- Net income
- -47,911,000 USD
- Operating cash flow
- -38,256,000 USD